It
Italfarmaco
Milan ITFounded 19383,500 employees
Private CappharmaPrivateHematologyRare Disease
Platform: Hematology
Market Cap
N/A
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gelilemzoparlimab | ITA-2260 | Approved | 3 | KRASG12D | ObesityMDD | ||
| ITA-4515 | ITA-4515 | Phase 3 | 2 | CD47 | Huntington's |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)